Yunlong Cui

1 article listing Yunlong Cui in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Perioperative tislelizumab plus lenvatinib treatment for resectable hepatocellular carcinoma at high risk of recurrence: single-arm phase II trial Nature Communications